Home » Topics » Ocular, BioWorld Science

Ocular, BioWorld Science
RSS

Bausch & Lomb acquires loteprednol etabonate line

Oct. 15, 2001

Asahi Glass describes novel antiglaucoma difluoroprostaglandins

Oct. 11, 2001

Indian research institute evaluates andrographolide derivatives

Sep. 21, 2001

Enrollment of patients completed for phase III INS-365 Ophthalmic clinical program

Sep. 19, 2001

Further submissions announced for Visudyne

Sep. 13, 2001

Novartis, QLT seek approval for expanded use of Visudyne in E.U.

Sep. 12, 2001

Senju to develop ocular formulation of betotastine

Sep. 4, 2001

Alcon presents potential antiglaucoma 13-oxaprostaglandins at the ACS meeting

Aug. 31, 2001

Sumitomo claims compounds useful for neuroretinal degenerative diseases

Aug. 31, 2001

Medennium's SmartPlug receives E.U. clearance for treatment of dry eyes

Aug. 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...